Molecular typing of Bordetella parapertussis isolates circulating in Pakistan

FEMS Immunology and Medical Microbiology

Volumn 63, Issue 3, 2011, Pages 373-380

  Bokhari, Habib ^a   Said, Fahad ^a   Syed, Muhammad A ^a   Mughal, Amjad ^b   Kazi, Yasmin F ^b   Kallonen, Teemu ^c   He, Qiushui ^c   King, Audrey J ^d   Heuvelman, Kees ^d   Mooi, Frits R ^d  

^a COMSATS Institute of Information Technology ^*  (Pakistan)

^b Department of Microbiology   (Pakistan)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Bordetella parapertussis; DTPw; Genetic heterogeneity; Pertussis; Vaccine

Indexed keywords

PERTACTIN; PERTUSSIS VACCINE;

ALLELE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BORDETELLA PARAPERTUSSIS; CHILD; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; DNA POLYMORPHISM; EUROPE; FINLAND; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MOLECULAR TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PAKISTAN; PERTUSSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SCHOOL CHILD; VACCINATION;

BACTERIAL OUTER MEMBRANE PROTEINS; BORDETELLA INFECTIONS; BORDETELLA PARAPERTUSSIS; CHILD; CHILD, PRESCHOOL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; INFANT; MICROARRAY ANALYSIS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PAKISTAN; VIRULENCE FACTORS, BORDETELLA;

EID: 80755167701     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00861.x     Document Type: Article

References (44)

1. Arico B & Rappuoli R (1987) Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol 169: 2847-2853.
2. Bokhari H, Fahad S, Syed MA, Mughal A, Kazi YF, Heuvelman K & Mooi FR (2011) Whooping cough in Pakistan: Bordetella pertussis vs Bordetella parapertussis in 2005-2009. Scand J Infect Dis 43: 818-820.
3. Borska K & Simkovicova M (1972) Studies on the circulation of Bordetella pertussis and Bordetella parapertussis in populations of children. J Hyg Epidemiol Microbiol Immunol 16: 159-172.
4. Bouchez V, Brun D, Dore G, Njamkepo E & Guiso N (2011) Bordetella parapertussis isolates not expressing pertactin circulating in France. Clin Microbiol Infect 17: 675-682.
5. Boursaux-Eude C & Guiso N (2000) Polymorphism of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica. Infect Immun 68: 4815-4817.
6. Byrne S & Slack A (2006) Analysis of Bordetella pertussis pertactin and pertussis toxin types from Queensland, Australia, 1999-2003. BMC Infect Dis 6: 53.
7. Cassiday P, Sanden G, Heuvelman K, Mooi FR, Bisgard KM & Popovic T (2000) Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis 12: 1402-1408.
8. David S, van Furth R & Mooi FR (2004) Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model. Vaccine 22: 1892-1898.
9. Diavatopoulos DA, Cummings CA, Schouls LM, Brinig MM, Relman DA & Mooi FR (2005) Bordetella pertussis, the causative agent of whooping cough, evolved from a distinct, human-associated lineage of B. bronchiseptica. PLoS Pathog 1: 373-383.
10. Eldering G & Kendrick PL (1938) Bacillus parapertussis: a species resembling both B. pertussis and B. bronchiseptica but identical with neither. J Bacteriol 35: 561-572.
11. Eldering G & Kendrick PL (1952) Incidence of parapertussis in the grand rapids area as indicated by 16 years' experience with diagnostic cultures. Am J Public Health 42: 27-31.
12. Gerlach G, Von Wintzingerode F, Middendorf B & Gross R (2001) Evolutionary trends in the genus Bordetella. Microbes Infect 3: 61-72.
13. Ghanaie RM, Karimi A, Sadeghi H, Esteghamti A, Falah F, Armin S, Fahimzad A, Shamshiri A, Khabazi M & Shiva F (2010) Sensitivity and specificity of the World Health Organization pertussis clinical case definition. Int J Infect Dis 14: e1072-e1075.
14. de Greeff SC, de Melker HE, van Gageldonk PGM, Schellekens JFP, Klis FRM, Mollema L, Mooi FR & Berbers GAM (2010) Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS ONE 5: e14183.
15. He Q, Edelman K, Arvilommi H & Mertsola J (1996a) Protective role of immunoglobulin G antibodies to filamentous hemagglutinin and pertactin of Bordetella pertussis and Bordetella parapertussis infection. Eur J Clin Microbiol Infect Dis 15: 793-798.
16. He Q, Schmidt-Schläpfer G, Just M, Matter HC, Nikkari S, Viljanen MK & Mersola J (1996b) Impact of polymerase chain reaction on clinical pertussis research: Finnish and Swiss experiences. J Infect Dis 174: 1288-1295.
17. He Q, Viljanen MK, Arvilommi H, Aittanen B & Mertsola J (1998) Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 280: 635-637.
18. Heininger U, Stehr K, Schmitt-Grobe S, Lorenz C, Rost R, Christenson PD, Uberall M & Cherry JD (1994) Clinical characteristics of illness caused by Bordetella pertussis compared with illness caused by Bordetella parapertussis. Pediatr Infect Dis J 13: 306-309.
19. King AJ, van Gorkom T, van der Heide HG, Advani A & van der Lee S (2010) Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift? BMC Genomics 26: 64.
20. Komatsu E, Yamaguchi F, Eguchi M & Watanabe M (2010) Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model. Vaccine 28: 4362-4368.
21. Kourova N, Caro V, Weber C, Thiberge S, Chuprinina R, Tseneva G & Guiso N (2003) Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian Vaccine Strains. J Clin Microbiol 41: 3706-3711.
22. Kurova N, Njamkepo E, Brun D, Tseneva G & Guiso N (2010) Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009. Res Microbiol 161: 810-815.
23. Lautrop H (1971) Epidemics of parapertussis: 20 years' observation in Denmark. Lancet 1: 1195-1198.
24. Lavine J, Broutin H, Harvill ET & Bjørnstad ON (2011) Imperfect vaccine-induced immunity and whooping cough transmission to infants. Vaccine 29: 11-16.
25. Liese JG, Renner C, Stojanov S & Belohradsky BH (2003) Clinical and epidemiological picture of B. pertussis and B. parapertussis infections after introduction of acellular pertussis vaccines. Arch Dis Child 88: 684-687.
26. Linnemann CC & Perry EB (1977) Bordetella parapertussis: recent experience and a review of the literature. Am J Dis Child 131: 560-563.
27. Maixnerova M (2003) The 2001 serological survey in the Czech Republic - parapertussis. Cent Eur J Public Health 11: S23-S24.
28. Mäkinen J, Mertsola J, Soini H, Arvilommi H, Viljanen MK, Guiso N & He Q (2003) PFGE and pertactin gene sequencing suggest limited genetic variability within the Finnish Bordetella parapertussis population. J Med Microbiol 52: 1059-1063.
29. Mastrantonio P, Giuliano M, Stefanelli P, Sofia T, De Marz L, Tarabini G, Quarto M & Moiraghi A (1997) Bordetella parapertussis infections. Dev Biol Stand 89: 255-259.
30. Mattoo S & Cherry JD (2005) Molecular pathogenesis, epidemiology and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bodetella subspecies. Clin Microbiol Rev 18: 326-382.
31. Mertsola J (1985) Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infections in Finland. Eur J Clin Microbiol 4: 123-128.
32. Miller JJ, Saito TM & Silverberg RJ (1941) Parapertussis: clinical and serologic observations. J Pediatr 19: 229-240.
33. Miller E, Vurdien JE & White JM (1992) The epidemiology of pertussis in England and Wales. Commun Dis Rep CDR Rev 4: R152-R154.
34. Mooi FR, Hallander H, Wirsing von König CH, Hoet B & Guiso N (2000) Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis 19: 174-181.
35. Parkhill J, Sebaihia M, Preston A et al. (2003) Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35: 32-40.
36. Preston A, Allen AG, Cadisch J, Thomas R, Stevens K, Churcher CM, Badcock KL, Parkhill J, Barrel B & Maskell DJ (1999) Genetic basis for lipopolysaccharide O-antigen biosynthesis in Bordetella. Infect Immun 67: 3763-3767.
37. Restif O, Wolfe DN, Goebel EM, Bjornstad ON & Harvill ET (2008) Of mice and men: asymmetric interactions between Bordetella pathogen species. Parasitology 135: 1517-1529.
38. Vysoka-Burianova B (1963) Contemporary problems in the epidemiology of whooping cough. J Hyg Epidemiol Microbiol Immunol 7: 472-481.
39. Watanabe M & Nagai M (2004) Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther 2: 447-454.
40. WHO (2010) Pertussis vaccines. WHO position paper. Wkly Epidemiol Rec 85: 385-400.
41. WHO/UNICEF (2009) WHO/UNICEF Review of National Immunization Coverage 1980-2008. WHO, Geneva.
42. Wirsing von König CH & Finger H (1994) Role of pertussis toxin in causing symptoms of Bordetella parapertussis infection. Eur J Clin Microbiol Infect Dis 13: 455-458.
43. Zawadka M, Polak M, Rabczenko D, Mosiej E, Augustynowicz E & Lutyńska A (2011) Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model. Vaccine 29: 5488-5494.
44. van der Zee A, Groenendijk H, Peeters M & Mooi FR (1996) The differentiation of Bordetella parapertussis and Bordetella bronchiseptica from humans and animals as determined by DNA polymorphism mediated by two different insertion sequence elements suggests their phylogenetic relationship. Int J Syst Bacteriol 46: 640-647.